- The Accuracy of Intraoperative Frozen Section of the Inguinal Sentinel Lymph Node in Vulvar Cancer
[作者：Brunner, AH; Polterauer, S; Tempfer, C; Joura, E; Reinthaller, A; Horvat, R; Hefler, L,期刊：Anticancer Research, 页码：4091-4094 , 文章类型： Article，,卷期：2008年28-6B]
- Background: Limited data are available for the accuracy of intraoperative frozen section analysis of inguinal sentinel lymph node in patients with vulvar cancer. Patients and Methods: Forty-four patients with vulvar canc...
- Neoadjuvant Chemoradiotherapy with 5-Fluorouracil by Bolus
[作者：Pasetto, LM; Sinigaglia, G; Basso, U; Cocchio, S; Compostella, A; Pucciarelli, S; Friso, ML; Rugge, M; Toppan, P; Agostini, M; Monfardini, S,期刊：Anticancer Research, 页码：4095-4100 , 文章类型： Article，,卷期：2008年28-6B]
- Background: Neoadjuvant chemoradiotherapy (CT-RT) with continuous infusion (c.i.) 5-fluorouracil (5-FU) before resection of high-risk rectal cancer improves overall survival (OS) and pelvic control. Since the presence of...
- The Combination of 5-Fluorouracil, Leukovorin, Etoposide, and Cisplatin (FLEP) in Patients with Metastatic Esophageal Cancer. A Single-institution Experience
[作者：Jonak, C; Raderer, M; Zacherl, J; Prager, G; Troch, M; Ba-Ssalamah, A; Hejna, M,期刊：Anticancer Research, 页码：4101-4104 , 文章类型： Article，,卷期：2008年28-6B]
- Background: A retrospective analysis was carried out on the efficacy and toxicity of the combination of 5-fluorouracil, leucovorin, etoposide and cisplatin (FLEP) in patients with metastatic esophageal cancer treated at ...
- Treatment with Cetuximab, Bevacizumab and Irinotecan in Heavily Pretreated Patients with Metastasized Colorectal Cancer
[作者：Halama, N; Herrmann, C; Jaeger, D; Herrmann, T,期刊：Anticancer Research, 页码：4111-4115 , 文章类型： Article，,卷期：2008年28-6B]
- Background: Modern therapy algorithms for advanced colorectal cancer include the monoclonal antibodies bevacizumab and cetuximab. Routinely, these antibodies are given sequentially in combination with chemotherapy. The q...
- Three-times Daily Radiotherapy after Chemotherapy in Stage III Non-small Cell Lung Cancer. Single-institution Prospective Study
[作者：Catalano, G; De Pas, T; Spaggiari, L; Gandini, S; Jereczek-Fossa, BA; De Braud, F; Leo, F; Veronesi, G; Orecchia, R,期刊：Anticancer Research, 页码：4121-4127 , 文章类型： Article，,卷期：2008年28-6B]
- Aim: A prospective study for stage IIIA-B non-small cell lung cancer (NSCLC), with three-times daily (3td) radiotherapy (RT), after induction chemotherapy (iCT), with or without surgery. Patients and Methods: Induction c...
- Role of Neoadjuvant Treatment in cT3N0M0 Rectal Cancer
[作者：Pasetto, LM; Friso, ML; Pucciarelli, S; Basso, U; Rugge, M; Sinigaglia, G; Rossi, E; Compostella, A; Toppan, P; Agostini, M; Monfardini, S,期刊：Anticancer Research, 页码：4129-4135 , 文章类型： Article，,卷期：2008年28-6B]
- Background: The aim of the study was to evaluate the pathological response (pTNM), local relapse and overall survival (OS) in clinical T3N0M0 (cT3N0M0) rectal cancer after a neoadjuvant chemoradiotherapy (CHT-RT) with 5-...
- Epirubicin and Cyclophosphamide Followed by Docetaxel as Primary Systemic Chemotherapy in Locally Advanced Breast Cancer
[作者：Hirano, A; Shimizu, T; Watanabe, O; Kinoshita, J; Kimura, K; Kamimura, M; Domoto, K; Aiba, M; Ogawa, K,期刊：Anticancer Research, 页码：4137-4142 , 文章类型： Article，,卷期：2008年28-6B]
- Background: The aim of this study was to evaluate the activity and toxicity of epirubicin and cyclophosphamide (EC) followed by docetaxel as primary systemic chemotherapy (PST) in locally advanced breast cancer. Patients...
|